Treatment Using Both Voclosporin and Belimumab in Four Patients With Lupus Nephritis

Nearly 50% of patients with systemic lupus erythematosus (SLE) will develop lupus nephritis (LN). Current treatment regimens for LN are suboptimal as the majority of patients fail to achieve complete renal response after several months of treatment and there are high rates of relapse. We report outc...

Descripción completa

Detalles Bibliográficos
Autores principales: Baum, Rebecca, Geetha, Duruvu, Fatola, Ayotola, Timlin, Homa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256255/
https://www.ncbi.nlm.nih.gov/pubmed/37303434
http://dx.doi.org/10.7759/cureus.38848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256255/
https://www.ncbi.nlm.nih.gov/pubmed/37303434
http://dx.doi.org/10.7759/cureus.38848

Ejemplares similares